Skip to main content
OpenTrials

Clinical trial condition

de Novo Myelodysplastic Syndromes

Explore clinical trials studying de Novo Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

62 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

de Novo Myelodysplastic Syndromes trial results

Completed

Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

NCT00451048

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • London Regional Cancer Program London, Ontario, Canada
  • Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

NCT00445744

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

NCT01101880

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +27 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

NCT00309907

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +86 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Oncology Group Arcadia, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 26 locations
View Trial Details

Related conditions